Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARγ (peroxisome proliferator-activated receptor γ) and RUNX2 (runt-related transcription factor 2)
- PMID: 29802142
- PMCID: PMC5971436
- DOI: 10.1074/jbc.W118.003815
Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARγ (peroxisome proliferator-activated receptor γ) and RUNX2 (runt-related transcription factor 2)
Retraction of
-
Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2).J Biol Chem. 2016 Nov 18;291(47):24475-24486. doi: 10.1074/jbc.M116.752493. Epub 2016 Sep 29. J Biol Chem. 2016. Retraction in: J Biol Chem. 2018 May 25;293(21):8314. doi: 10.1074/jbc.W118.003815. PMID: 27687725 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
